BioCentury
ARTICLE | Financial News

Nitric oxide play GeNO files for IPO

November 13, 2013 1:04 AM UTC

GeNO LLC (Cocoa, Fla.) filed to raise up to $50 million in an IPO underwritten by Jefferies; Stifel; and Canaccord. GeNO is developing inhaled nitric oxide (NO) therapies based on its GeNOsyl drug del...